Regulation and Safety, in Plain Language
Why this page exists
Patients considering regenerative therapy abroad have a reasonable concern: how do I know this is regulated at all? It is a fair question, and the honest answer is that the regulatory picture varies enormously from clinic to clinic. This page explains the specific protections that apply to the cells used at RegenaMex, in language that does not require a medical or legal background.
What COFEPRIS is
COFEPRIS is Mexico’s federal commission for protection against sanitary risks, the national health authority. It is the Mexican equivalent, in function, of the kind of agency that regulates medicines and medical establishments in other countries. COFEPRIS issues sanitary licenses, inspects facilities, and sets the standards that medical and biological products must meet to operate legally.
When we say our cell source is COFEPRIS-authorized, we mean it holds a formal sanitary license, authorization number 18-TR-14-120-0001, to operate as a stem cell bank. This is verifiable. It is not a private certificate or an internal quality badge.
What the authorization covers
The authorization registers CBCells as a Banco de Celulas Progenitoras o Troncales, a bank of progenitor or stem cells. In practical terms, this means the entity is licensed to process and bank the type of cells used in regenerative therapy, under the oversight of the federal health authority, subject to the conditions of that license.
We want to be careful about what this does and does not mean. The license covers the legitimacy and oversight of the cell source. It is a statement about process, facility, and regulatory standing. It is not, by itself, a guarantee of a clinical outcome for any individual patient. Those are two different things, and we keep them separate on purpose.
What GMP processing adds
Beyond the license itself, the cells are processed under Good Manufacturing Practice conditions. GMP is the framework that governs how a biological product is handled from start to finish:
Consistency
Every batch is processed under the same defined protocols, so the product does not vary unpredictably from one preparation to the next.
Traceability
There is documentation for each batch, which means the path of the material can be followed and accounted for.
Contamination control
The processing happens in a controlled environment specifically designed to keep the product free from contamination.
For a patient, these three things are the difference between a product that has been prepared to a defined standard and one that simply arrives with assurances.
Our approach to safety claims
We hold ourselves to a simple rule on this site: we will tell you what is documented, and we will not imply more than the documents support. The COFEPRIS license and GMP processing are real, verifiable protections around the source and handling of the cells. They are meaningful. They are also not a promise that any therapy will produce a specific result for you. A responsible clinic states both halves of that sentence, and we do.
What to Do Next
Review our Our Cells page to see the license itself. Read our Published Research page to understand the independent validation of the cell source. Then speak with our team about your specific situation, including realistic expectations and any risks relevant to you.
The information on this page is for educational purposes and describes the source, licensing, and processing of the cells used in our therapies. It is not a guarantee of any specific medical outcome. Regenerative therapies are not a substitute for conventional medical care. Speak with a qualified physician about whether any treatment is appropriate for your individual situation.